Open AccessLarge Ostium Secundum ASD Occlusion with Memopart ASD Occluder
Author(s) -
Veeraj V. Kalburgi
Publication year - 2022
Publication title -
international journal of medical science and clinical research studies
Language(s) - English
Resource type - Journals
eISSN - 2767-8342
pISSN - 2767-8326
DOI - 10.47191/ijmscrs/v2-i2-05
Subject(s) - medicine , complication , surgery , percutaneous , closure (psychology) , occlusion , foramen secundum , cohort , patent foramen ovale , economics , market economy
Transcatheter occlusion of ASD with device is an effective,alternative to surgical repair : feasible and safe procedure with minimal complication rate and short hospital stay, as well as excellent short and long term outcome .However, large ASDs (>38 mm) and defects with deficient rims are usually not offered transcatheter closure but are referred for surgical closure. Transcatheter closure also remains controversial for other complicated ASDs with comorbidities, additional cardiac features and in small children. Previous studies have shown high success rate, low complication rate and less discomfort[1,2] . With the devices and technology currently available, several cohort studies have reported successful percutaneous closure in the above-mentioned complex cases. However the feasibility and safety of transcatheter technique needs to be confirmed through larger studies and longer follow-up.